Marvell's (MRVL +0.3%) price target is lifted $2 to $15 by RBC's Doug Freedman post-earnings, noting the low-end of FQ2 guidance is above both his and Street estimates. Needham ups its PT $3 to $15. Both maintain Buy ratings. Something didn't sit well with JMP Securities which cuts to Sell with $8 PT. Perhaps the stock's 57% YTD run has priced the good news in. Shares have given up big premarket gains.